# Dianthus Therapeutics, Inc.: Form 8-K, filed Jun 11, 2019

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: 8-K
- Filed: 2019-06-11
- Accepted by EDGAR: Jun 11, 2019, 16:43 ET
- Period: 2019-06-07
- Accession: 0001193125-19-170256
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000119312519170256/d742816d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000119312519170256/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000119312519170256/d742816d8k.htm

Filed Jun 11, 2019.
Source: SEC EDGAR, the filing index for accession 0001193125-19-170256. Last ingested by Listed: Nov 13, 2026, 16:49 ET. No prices; not investment advice.